Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. reports on the minutes of the Board of Directors meeting held on May 15, 2018. The document details corporate governance actions, executive appointments, dividend declarations, and authorization of financial instruments. The reporting period covers decisions effective from April 30, 2018, through July 1, 2018.
Key Financial Metrics and Capital Actions
- Dividend Declaration: The Board approved a dividend of R$ 0.16 per share, to be deducted from 2018 fiscal year results and attributed to minimum mandatory dividends.
- Payment Schedule: Payment is scheduled for July 30, 2018 (subject to shareholder meeting approval). The record date is June 15, 2018 (B3) and June 19, 2018 (NYSE). Shares trade ex-dividend starting June 18, 2018.
- Equity Swap Authorization: The Board authorized equity swap agreements with a maximum exposure of 80 million common shares (or ADRs) and a limit value of up to R$ 1.8 billion.
- Share Capital: As of the filing, there are 4,347,496,817 outstanding shares. The Company holds 3,757,318 shares in treasury.
- Financial Performance: The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the period.
Material Changes and Corporate Governance
- Executive Officer Change: Mr. Fernando Mommensohn Tennenbaum was appointed as the new Chief Financial and Investor Relations Officer, effective July 1, 2018, replacing Mr. Ricardo Rittes de Oliveira Silva. His mandate expires on July 1, 2021.
- Board of Directors Change: Mr. Álvaro Antônio Cardoso de Souza resigned effective April 30, 2018. Mr. Nelson José Jamel was appointed as a Board member to fill the vacancy, with a term until the 2020 Annual General Shareholders' Meeting.
- Committee Re-elections: The Operations, Finance and Compensation Committee and the Antitrust Compliance and Related Parties Committee were re-elected with terms extending until the 2019 fiscal year resolution.
- Extraordinary Balance Sheet: The Board determined the preparation of an extraordinary balance sheet as of April 30, 2018, to support the dividend declaration.
Outlook, Risks, and Contingencies
- Purpose of Equity Swaps: The authorized swaps are intended to hedge against stock price oscillations affecting the Company's share-based payment programs. They are financially settled and will not involve the physical purchase or disposal of shares.
- Termination Clauses: Counterparties may terminate swap agreements if the share price depreciates by 50% or more. The Company retains the option to terminate contracts at its sole discretion.
- Financial Impact: The Board confirmed that the Company's current financial situation is compatible with these operations and that they will not affect obligations to creditors or the payment of mandatory dividends.
- Settlement Term: The maximum term for settlement of the authorized equity swap operations is 18 months, ending November 15, 2019.
Investor Verification Checklist
- Verify the ex-dividend date of June 18, 2018 for eligibility to receive the R$ 0.16 per share dividend.
- Confirm the effective date of the new CFO, Fernando Mommensohn Tennenbaum, on July 1, 2018.
- Monitor the execution of equity swap agreements to ensure total exposure does not exceed the authorized limit of 80 million shares or R$ 1.8 billion.
- Review the upcoming Annual General Shareholders' Meeting to confirm the final approval of the dividend payment.